Literature DB >> 28468530

The Epigenetics of Epilepsy and Its Progression.

Rebecca M Hauser1, David C Henshall2, Farah D Lubin1.   

Abstract

Epilepsy is a common and devastating neurological disorder characterized by recurrent and unprovoked spontaneous seizures. One leading hypothesis for the development and progression of epilepsy is that large-scale changes in gene transcription and protein expression contribute to aberrant network restructuring and hyperexcitability, resulting in the genesis of repeated seizures. Current research shows that epigenetic mechanisms, including posttranslational alterations to the proteins around which DNA is coiled, chemical modifications to DNA, and the activity of various noncoding RNA molecules exert important influences on these gene networks in experimental epilepsy. Key findings from animal models have been replicated in humans using brain tissue obtained from living patients at the time of neurosurgical resection for pharmacoresistant epilepsy. These findings have spurred efforts to target epigenetic processes to disrupt or modify epilepsy in experimental models with varying degrees of success. In this review, we will (1) summarize the epigenetic mechanisms implicated in epileptogenesis and epilepsy, (2) explore the influence of metabolic factors on epigenetic mechanisms, and (3) assess the potential of using epigenetic markers to support diagnosis and prognosis. Translation of these findings may guide the development of molecular biomarkers and novel therapeutics for prevention or modification of epileptic disorders.

Entities:  

Keywords:  DNA methylation; anticonvulsant drug; epigenetics; hippocampus; histones; lncRNA; metabolism; microRNA; temporal lobe epilepsy

Mesh:

Year:  2017        PMID: 28468530     DOI: 10.1177/1073858417705840

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  32 in total

1.  RASgrf1, a Potential Methylatic Mediator of Anti-epileptogenesis?

Authors:  Yi Bao; Xiaoni Chen; Liang Wang; Jixiu Zhou; Xinwei Fu; Xuefeng Wang; Zheng Xiao
Journal:  Neurochem Res       Date:  2018-09-21       Impact factor: 3.996

Review 2.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

3.  Extracellular Vesicles in the Forebrain Display Reduced miR-346 and miR-331-3p in a Rat Model of Chronic Temporal Lobe Epilepsy.

Authors:  Daniel Leite Góes Gitaí; Ygor Daniel Ramos Dos Santos; Raghavendra Upadhya; Maheedhar Kodali; Leelavathi N Madhu; Ashok K Shetty
Journal:  Mol Neurobiol       Date:  2019-12-07       Impact factor: 5.590

Review 4.  A putative role for lncRNAs in epigenetic regulation of memory.

Authors:  Ashleigh B Irwin; Rudhab Bahabry; Farah D Lubin
Journal:  Neurochem Int       Date:  2021-09-14       Impact factor: 3.921

Review 5.  MicroRNA-induced silencing in epilepsy: Opportunities and challenges for clinical application.

Authors:  Durgesh Tiwari; Katrina Peariso; Christina Gross
Journal:  Dev Dyn       Date:  2017-10-04       Impact factor: 3.780

Review 6.  Ketogenic diet, neuroprotection, and antiepileptogenesis.

Authors:  Madhuvika Murugan; Detlev Boison
Journal:  Epilepsy Res       Date:  2020-08-19       Impact factor: 3.045

7.  Disease Modification in Epilepsy: Behavioural Accompaniments.

Authors:  Emilio Russo; Rita Citraro
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 8.  Role of Adenosine in Epilepsy and Seizures.

Authors:  Fabio C Tescarollo; Diogo M Rombo; Lindsay K DeLiberto; Denise E Fedele; Enmar Alharfoush; Ângelo R Tomé; Rodrigo A Cunha; Ana M Sebastião; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2020-06-04

Review 9.  MicroRNAs as regulators of brain function and targets for treatment of epilepsy.

Authors:  Gary P Brennan; David C Henshall
Journal:  Nat Rev Neurol       Date:  2020-06-16       Impact factor: 42.937

Review 10.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.